Literature DB >> 17898337

Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Daniel Weintraub1, Howard I Hurtig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17898337      PMCID： PMC2137166          DOI： 10.1176/appi.ajp.2007.07040715

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  55 in total

Review 1.  Intrinsic and extrinsic psychosis in Parkinson's disease.

Authors:  E C Wolters
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

Review 2.  An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

Authors:  C W Olanow; R L Watts; W C Koller
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

3.  Clozapine and risperidone treatment of psychosis in Parkinson's disease.

Authors:  T Ellis; M E Cudkowicz; P M Sexton; J H Growdon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

4.  Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.

Authors:  Jeffrey L Cummings; Jamie Street; Donna Masterman; W Scott Clark
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

5.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

Authors:  A J Harding; G A Broe; G M Halliday
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

6.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Authors:  I McKeith; T Del Ser; P Spano; M Emre; K Wesnes; R Anand; A Cicin-Sain; R Ferrara; R Spiegel
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

7.  Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

Authors:  D Aarsland; J P Larsen; E Tandberg; K Laake
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

8.  Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.

Authors:  D Aarsland; K Laake; J P Larsen; C Janvin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

9.  Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors: 
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

10.  Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.

Authors:  K A Wesnes; I G McKeith; R Ferrara; M Emre; T Del Ser; P F Spano; A Cicin-Sain; R Anand; R Spiegel
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959
View more
  15 in total

1.  Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.

Authors:  Aurelia Ces; David Reiss; Ondine Walter; Jürgen Wichmann; Eric P Prinssen; Brigitte L Kieffer; Abdel-Mouttalib Ouagazzal
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

Review 2.  [Therapy of psychological and behavioral symptoms in dementia].

Authors:  F Jessen; A Spottke
Journal:  Nervenarzt       Date:  2010-07       Impact factor: 1.214

3.  Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.

Authors:  Daniel Weintraub; Peijun Chen; Rosalinda V Ignacio; Eugenia Mamikonyan; Helen C Kales
Journal:  Arch Neurol       Date:  2011-07

Review 4.  Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.

Authors:  Eduardo Prado; Pongsatorn Paholpak; Myha Ngo; Verna Porter; Liana G Apostolova; Rogério Marrocos; John M Ringman
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-14       Impact factor: 2.035

Review 5.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

Review 6.  Psychiatric symptoms in Parkinson's disease.

Authors:  Frank Schneider; Astrid Althaus; Volker Backes; Richard Dodel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

Review 7.  Management of non-motor complications in Parkinson's disease.

Authors:  Ken-ichi Fujimoto
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

Review 8.  Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit.

Authors:  Hochang B Lee; Candyce J DeLoatch; SeongJin Cho; Paul Rosenberg; Simon C Mears; Frederick E Sieber
Journal:  Crit Care Clin       Date:  2008-10       Impact factor: 3.598

9.  The geriatric population and psychiatric medication.

Authors:  Sannidhya Varma; Himanshu Sareen; J K Trivedi
Journal:  Mens Sana Monogr       Date:  2010-01

10.  A clinical profile of patients with Parkinson's disease and psychosis.

Authors:  B R Amar; Ravi Yadav; Y C Janardhan Reddy; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.